Welcome to the New South Wales health ecosystem

[On Demand]
Professor Hugh Durrant-Whyte, New South Wales Chief Scientist and Anne O'Neill Director Enterprise and International Partnerships Office at NSW Health introduce NSW Health Ecosystem with opportunities for research collaboration, global biotech investors, and a thriving medtech ecosystem.

NSW’s strong foundations and effective response to COVID-19, positioned NSW as preferential location for productive foreign direct investment. NSW remains destination of choice for Clinical Trials. During Covid pandemic remained open for important medical research, including for non-COVID-19 medical research during the pandemic.

NSW leads the way in gene and cell therapy and a new proposed $25 million world leading advanced viral vector manufacturing facility in the Westmead Health & Innovation District will give patients with genetic diseases, cancers and viral infections across Australia faster access to ground-breaking trial therapies.
NSW Chief Scientist & Engineer